Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
EIGR

EIGR - Eiger BioPharmaceuticals Inc Stock Price, Fair Value and News

$1.73 
Market Closed

Price Targets

EIGR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EIGR Price Action

Trailing 12 Months

-19.5%

EIGR RSI Chart

EIGR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EIGR Valuation

EIGR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

EIGR Fundamentals

EIGR Revenue

EIGR Earnings

EIGR Profitability

EIGR Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023015.5M14.6M14.4M
202211.2M13.2M14.1M13.5M
202100012.1M
Get all data in R, Python etc through our Historical Stock Data APIs

About Eiger BioPharmaceuticals Inc

EIGR
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targets type III interferon receptors that has completed Phase II clinical trials; Lonafarnib for the treatment of progeria and progeroid laminopathies; and Avexitide for the treatment of congenital hyperinsulinism, as well as has completed Phase II clinical trials to treat post-bariatric hypoglycemia. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is headquartered in Palo Alto, California.
 CEO
 WEBSITEeigerbio.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES56

Eiger BioPharmaceuticals Inc Frequently Asked Questions

EIGR is the stock ticker symbol of Eiger BioPharmaceuticals Inc. Every public company that trades on a stock exchange gets a ticker symbol.

You can check EIGR's fair value in chart for subscribers.

The fair value guage provides a quick view whether EIGR is over valued or under valued. Whether Eiger BioPharmaceuticals Inc is cheap or expensive depends on the assumptions which impact Eiger BioPharmaceuticals Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EIGR.

In the past 10 years, Eiger BioPharmaceuticals Inc has provided -0.471 (multiply by 100 for percentage) rate of return.